Australian researchers say they have developed a designer cytokine – IC7Fc – that promises to have multiple actions to treat type 2 diabetes. The novel molecule IC7Fc combines the effects of interleukin-6 (IL-6) and ciliary neurotrophic factor (CNTF) to improve glucose tolerance and hyperglycaemia and prevent weight gain and liver steatosis, according to Professor Mark Febbraio, ...
Designer cytokine may be the next treatment for T2D
By Michael Woodhead
26 Sep 2019